(Q42931755)

11 November 2017

title

Management of intractable hypoglycemia with Yttirum-90 radioembolization in a patient with malignant insulinoma (English)

1 reference

11 November 2017

Management of Intractable Hypoglycemia With Yttirum-90 Radioembolization in a Patient With Malignant Insulinoma (English)

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

20 June 2024

1 reference

Prakash Chandra

1

1 reference

11 November 2017

Shadi Sadeghi Yarandi

2

1 reference

11 November 2017

Natasha Khazai

3

1 reference

11 November 2017

Sol Jacobs

4

1 reference

11 November 2017

Guillermo E. Umpierrez

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20724903

20 June 2024

language of work or name

English

0 references

publication date

1 November 2010

1 reference

full work available at URL

11 November 2017

https://api.elsevier.com/content/article/PII:S0002962915314592?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

https://api.elsevier.com/content/article/PII:S0002962915314592?httpAccept=text/plain

20 June 2024

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

American Journal of the Medical Sciences

20 June 2024

published in

1 reference

11 November 2017

volume

340

1 reference

11 November 2017

issue

5

1 reference

11 November 2017

page(s)

414-417

1 reference

The diagnosis and medical management of advanced neuroendocrine tumors.

11 November 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Malignant metastatic insulinoma-postoperative treatment and follow-up

20 June 2024

2

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

The management of insulinoma

20 June 2024

3

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.

20 June 2024

4

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Malignant insulinomas with hepatic metastases successfully treated with selective internal radiation therapy.

20 June 2024

5

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Therapies for the medical management of persistent hypoglycaemia in two cases of inoperable malignant insulinoma.

20 June 2024

6

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Islet cell carcinoma: neuroendocrine tumors of the pancreas and periampullary region

20 June 2024

7

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Streptozocin–Doxorubicin, Streptozocin–Fluorouracil, or Chlorozotocin in the Treatment of Advanced Islet-Cell Carcinoma

20 June 2024

8

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Failure to confirm major objective antitumor activity for streptozocin and doxorubicin in the treatment of patients with advanced islet cell carcinoma

20 June 2024

9

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Doxorubicin, streptozocin, and 5-fluorouracil chemotherapy for patients with metastatic islet-cell carcinoma

20 June 2024

10

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Fluorouracil, doxorubicin, and streptozocin in the treatment of patients with locally advanced and metastatic pancreatic endocrine carcinomas

20 June 2024

11

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Glycemic control in patients with insulinoma treated with everolimus

20 June 2024

12

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Successful control of intractable hypoglycemia using rapamycin in an 86-year-old man with a pancreatic insulin-secreting islet cell tumor and metastases

20 June 2024

13

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Transplant-associated hyperglycemia: a new look at an old problem

20 June 2024

14

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

TOR signaling in growth and metabolism

20 June 2024

15

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

The impact of the mTOR inhibitor sirolimus on the proliferation and function of pancreatic islets and ductal cells

20 June 2024

16

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

mTOR inhibition by rapamycin prevents beta-cell adaptation to hyperglycemia and exacerbates the metabolic state in type 2 diabetes

20 June 2024

17

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Efficacy of RAD001 (everolimus) and octreotide LAR in advanced low- to intermediate-grade neuroendocrine tumors: results of a phase II study

20 June 2024

18

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Daily oral everolimus activity in patients with metastatic pancreatic neuroendocrine tumors after failure of cytotoxic chemotherapy: a phase II trial

20 June 2024

19

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Gastroenteropancreatic neuroendocrine tumours

20 June 2024

20

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Peptide receptor expression in GEP-NET.

20 June 2024

21

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

The somatostatin receptor-targeted radiotherapeutic [90Y-DOTA-DPhe1, Tyr3]octreotide (90Y-SMT 487) eradicates experimental rat pancreatic CA 20948 tumours

20 June 2024

22

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.

20 June 2024

24

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Hepatic radioembolization with yttrium-90 containing glass microspheres: preliminary results and clinical follow-up

20 June 2024

25

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

Radioembolization with selective internal radiation microspheres for neuroendocrine liver metastases

20 June 2024

26

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

90Y Radioembolization for metastatic neuroendocrine liver tumors: preliminary results from a multi-institutional experience.

20 June 2024

27

1 reference

https://api.crossref.org/works/10.1097/MAJ.0B013E3181EE7BE2

20 June 2024

Identifiers

1 reference

11 November 2017

1 reference